Cita APA (7a ed.)
Sachpekidis, C., Anwar, H., Winkler, J., Kopp-Schneider, A., Larribere, L., Haberkorn, U., . . . Dimitrakopoulou-Strauss, A. (2018). The role of interim 18F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma. European Journal of Nuclear Medicine & Molecular Imaging, 45(8), 1289-1297.
Cita Chicago Style (17a ed.)
Sachpekidis, Christos, Hoda Anwar, Julia Winkler, Annette Kopp-Schneider, Lionel Larribere, Uwe Haberkorn, Jessica C. Hassel, y Antonia Dimitrakopoulou-Strauss. "The Role of Interim 18F-FDG PET/CT in Prediction of Response to Ipilimumab Treatment in Metastatic Melanoma." European Journal of Nuclear Medicine & Molecular Imaging 45, no. 8 (2018): 1289-1297.
Cita MLA (9a ed.)
Sachpekidis, Christos, et al. "The Role of Interim 18F-FDG PET/CT in Prediction of Response to Ipilimumab Treatment in Metastatic Melanoma." European Journal of Nuclear Medicine & Molecular Imaging, vol. 45, no. 8, 2018, pp. 1289-1297.
Precaución: Estas citas no son 100% exactas.